UK approves its first vaccine

Welcome to Business Insider‘s daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.

Hi,

The UK has approved Pfizer and BioNTech’s coronavirus vaccine, becoming the first Western country to give a vaccine an OK. The plan is to make the vaccine available next week. 

In the European Union and US, an official OK might still be a few weeks away as regulatory bodies analyze the data in different ways.

Also in healthcare news: US health officials set their recommendations for who should get vaccinated first, a bipartisan stimulus bill is on the table, and the checklist the head of Cigna’s venture fund uses to vet potential investments. 

Healthcare workers and long-term care facility residents should get a coronavirus vaccine first, according to US health officials

• The CDC's Advisory Committee on Immunization Practices voted on Tuesday to recommend that healthcare workers and long-term care facility residents should receive a coronavirus vaccine first.
• Vaccinating healthcare workers first would allow them to continue to respond to the pandemic.
• Those living in nursing homes and assisted living facilities have experienced high rates of COVID-19 cases and deaths.
• ACIP's recommendation will help the government decide who gets the first doses of a vaccine once it is authorized.

Read the full story from Andrea Michelson here>>

Lawmakers just unveiled a $908 billion coronavirus stimulus deal that would boost unemployment payments and help small businesses. Here's what's in the package.

• A bipartisan group of lawmakers, including Sens. Joe Manchin and Susan Collins, just unveiled a $908 billion package to try to end the gridlock over a coronavirus stimulus.
• Their plan is almost double what Senate Majority Leader Mitch McConnell wants to spend and less than half of what Democratic leadership — and President Donald Trump — have pushed for.
• Virginia Democratic Sen. Mark Warner, who was among the negotiators, said it would be "stupidity on steroids" for Congress to leave for the winter break without passing a stimulus.

Read the full story from Kimberly Leonard here>>

The man behind Cigna's $250 million venture fund shares the 3-part checklist he uses to place his bets on healthcare startups, including how he judges founders' problem-solving skills

• Tom Richards, head of Cigna's global business development, shared his criteria for healthcare bets with Business Insider.
• Cigna likes to bet on companies that are tackling specific problems that Cigna is also facing. As a huge health plan, it's often a customer to the same vendors it bets on.
• When it comes to the leadership team, Richards puts a premium on their ability to respond to evolving problems and change their solution accordingly. 

Read the full story from Blake Dodge here>>

More stories we're reading:

• UnitedHealth Group expects it will lose $2 billion because of COVID-19 in 2021 (Bloomberg)
• Trump's vaccine czar said he has 'no reason to believe' the FDA has altered how it reviews COVID-19 vaccines, amid reports of the president's frustration over how long the process takes (Business Insider)
• When should inmates get COVID-19 vaccines? (The New York Times)
• Pfizer and Moderna have both asked the EU to approve their COVID-19 vaccines — but first shots might not come until next year (Business Insider)

- Lydia